ARTICLE | Clinical News
XL281: Phase I start
October 23, 2006 7:00 AM UTC
EXEL submitted an IND to FDA to begin a Phase I trial in late 2006 or early 2007. ...
Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
EXEL submitted an IND to FDA to begin a Phase I trial in late 2006 or early 2007. ...